Quest Diagnostics Partnering Lee Health To Enhance Diagnostic Services
(RTTNews) - Quest Diagnostics (DGX), a provider of diagnostic information services, and Lee Health, Southwest Florida's primary community-owned health system, announced Thursday that they are teaming up to enhance the quality and value of diagnostic services to patients and their doctors.
Under the agreement, Quest will provide supply chain expertise in laboratory equipment, supplies and procurement processes for five hospitals owned by Lee Health and selected outpatient centers. Quest will also continue to perform reference testing for Lee Health.
read more
Haystack Oncology And Lisata Therapeutics Partner To Evaluate Efficacy Of Pancreatic Cancer Therapy
Haystack Oncology, a Quest Diagnostics (DGX) company, and Lisata Therapeutics, Inc. (LSTA), a clinical-stage pharmaceutical company, announced Thursday a research collaboration to use the Haystack MRD Technology to evaluate efficacy of Pancreatic Cancer Therapy.
RTTNews
|
hace 180
Quest Diagnostics To Acquire Outreach Laboratory Services Of OhioHealth
Quest Diagnostics (DGX), a provider of diagnostic information services, and OhioHealth, a nationally recognized not-for-profit, charitable, integrated health system, announced Wednesday a definitive agreement for Quest to acquire select assets of OhioHealth's outreach laboratory services business.
RTTNews
|
hace 188
Quest Diagnostics To Acquire LifeLabs From OMERS In About $985 Mln Deal
Quest Diagnostics (DGX), a provider of diagnostic information services, announced Wednesday a definitive agreement to acquire LifeLabs, a provider of community laboratory tests for millions of Canadians, from OMERS for a value of approximately C$1.35 billion (approximately $985 million), including net debt.
RTTNews
|
hace 195
Quest Diagnostics Awarded Contract To Assess Burden Of Hepatitis C Virus In U.S By CDC
Quest Diagnostics (DGX), a leading provider of hepatitis testing services, announced Thursday it has been awarded a contract by the U.S. Centers for Disease Control and Prevention (CDC) designed to assess the burden of hepatitis C virus (HCV) in the U.S.
RTTNews
|
hace 404
Quest, Scipher Team Up To Expand Diagnostic Services Access For Patients With Rheumatoid Arthritis
Diagnostic services provider Quest Diagnostics (DGX) and precision immunology company Scipher Medicine announced Tuesday a multi-pronged collaboration designed to expand patient access to diagnostic services advancing precision medicine for rheumatoid arthritis (RA).
RTTNews
|
hace 413
Quest Diagnostics Narrows FY23 Adj. EPS Outlook Range, Boosts Revenue Forecast - Update
While reporting financial results for the third quarter on Wednesday, Quest Diagnostics Inc. (DGX) narrowed its earnings and adjusted earnings guidance range for the full-year 2023, while raising annual revenue outlook.
RTTNews
|
hace 448
Quest Diagnostics Says FDA Grants Breakthrough Designation For Adeno-associated Virus Test
Quest Diagnostics (DGX), a diagnostic information services provider, announced Wednesday that its AAVrh74 ELISA assay (CDx) has been granted Breakthrough Device Designation from the U.S. Food and Drug Administration (FDA).
RTTNews
|
hace 503
Quest Diagnostics Boosts FY23 Adj. EPS, Revenue Outlook - Update
While reporting financial results for the second quarter on Wednesday, Quest Diagnostics Inc. (DGX) raised its adjusted earnings and revenue guidance for the full-year 2023.
RTTNews
|
hace 538
